Lv67
2760 积分 2023-10-09 加入
Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule
2个月前
已完结
[ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study
3个月前
已完结
Fibroblast Activation Protein Inhibitor Theranostics
3个月前
已完结
Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here?
3个月前
已完结
Novel Fibroblast Activation Protein Inhibitor-Based Targeted Theranostics for Radioiodine-Refractory Differentiated Thyroid Cancer Patients: A Pilot Study
3个月前
已完结
Dosimetry of [177Lu]Lu-PSMA–Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis
3个月前
已完结
[Efficacy and safety of Anlotinib in the treatment of advanced sarcoma]
3个月前
已完结
Current Status and Perspectives of Novel Radiopharmaceuticals with Heterologous Dual-targeted Functions: 2013–2023
3个月前
已完结
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
4个月前
已完结
Preclinical evaluation of a dual-receptor targeted tracer [68Ga]Ga-HX01 in 10 different subcutaneous and orthotopic tumor models
4个月前
已完结
皖公网安备34019202002308
